To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to primarily assess the effect of aliskiren on albuminuria in patients
with non-diabetic nephropathy when treated with ramipril and volume intervention.